UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy

Journal of pharmacological sciences, 2022-01, Vol.148 (1), p.31-40

2022

Volltextzugriff (PDF)

Uric Acid Elevation by Favipiravir, an Antiviral Drug

The Tohoku Journal of Experimental Medicine, 2020, Vol.251(2), pp.87-90

2020

Volltextzugriff (PDF)

Mechanisms underlying sensitization of P2X7 receptors in astrocytes for induction of ischemic tolerance

Glia, 2021-09, Vol.69 (9), p.2100-2110

2021

Volltextzugriff (PDF)

l‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth

Cancer science, 2010-01, Vol.101 (1), p.173-179

2010

Volltextzugriff (PDF)

Functional Expression of Organic Ion Transporters in Astrocytes and Their Potential as a Drug Target in the Treatment of Central Nervous System Diseases

Biological and Pharmaceutical Bulletin, 2017/08/01, Vol.40(8), pp.1153-1160

2017

Volltextzugriff (PDF)

P2X7 Receptors in Astrocytes: A Switch for Ischemic Tolerance

Molecules (Basel, Switzerland), 2022-06, Vol.27 (12), p.3655

2022

Volltextzugriff (PDF)

L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism

Scientific reports, 2021-01, Vol.11 (1), p.589-589, Article 589

2021

Volltextzugriff (PDF)

Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment

World journal of gastrointestinal oncology, 2017-01, Vol.9 (1), p.21-29

2017

Volltextzugriff (PDF)

Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma

Scientific reports, 2020-01, Vol.10 (1), p.1292-1292, Article 1292

2020

Volltextzugriff (PDF)

Organic Anion Transporter Family: Current Knowledge

Journal of Pharmacological Sciences, 2006, Vol.100(5), pp.411-426

2006

Volltextzugriff (PDF)

Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective

Journal of pharmacological sciences, 2022-12, Vol.150 (4), p.251-258

2022

Volltextzugriff (PDF)

JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function

Journal of pharmacological sciences, 2020-09, Vol.144 (1), p.16-22

2020

Volltextzugriff (PDF)

Contribution of Rare Variants of the SLC22A12 Gene to the Missing Heritability of Serum Urate Levels

Genetics (Austin), 2020-04, Vol.214 (4), p.1079-1090

2020

Volltextzugriff (PDF)

Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways

Cancers, 2022-01, Vol.14 (1), p.229

2022

Volltextzugriff (PDF)

LAT1-specific inhibitor ameliorates severe autoimmune arthritis in SKG mouse

International immunopharmacology, 2022-08, Vol.109, p.108817-108817, Article 108817

2022

Volltextzugriff (PDF)

The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2

Scientific reports, 2021-06, Vol.11 (1), p.11478-11478, Article 11478

2021

Volltextzugriff (PDF)

Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans

The Journal of biological chemistry, 2008-10, Vol.283 (40), p.26834-26838

2008

Volltextzugriff (PDF)

Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma

Scientific reports, 2019-11, Vol.9 (1), p.16776-10, Article 16776

2019

Volltextzugriff (PDF)

Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203

Anticancer research, 2019-01, Vol.39 (1), p.159-165

2019

Volltextzugriff (PDF)

c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells

Oncology reports, 2012-09, Vol.28 (3), p.862-866

2012

Volltextzugriff (PDF)

Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6178

2023

Volltextzugriff (PDF)

Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies

Clinical and experimental nephrology, 2012-02, Vol.16 (1), p.89-95

2012

Volltextzugriff (PDF)

Cystine-dependent antiporters buffer against excess intracellular reactive sulfur species-induced stress

Redox biology, 2022-11, Vol.57, p.102514-102514, Article 102514

2022

Volltextzugriff (PDF)

Effects of a novel hepatitis B anti-viral drug E-CFCP in renal organic acid transporters

Journal of pharmacological sciences, 2022-12, Vol.150 (4), p.201-203

2022

Volltextzugriff (PDF)

Fluvastatin is effective against thymic carcinoma

Life sciences (1973), 2020-01, Vol.240, p.117110, Article 117110

2020

Volltextzugriff (PDF)

1 – 25 von 418

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(316)
Mit Volltextzugriff
(343)

Publikationsform

Sprache

Englisch
(321)
Japanisch
(126)
Croatian
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(184)
Life Sciences & Biomedicine
(175)
Humans
(111)
Animals
(105)
Male
(58)
Pharmacology & Pharmacy
(56)
Female
(34)
Mice
(34)
Rats
(34)
Kidney - Metabolism
(31)
Biological Transport
(29)
Organic Anion Transporters - Metabolism
(28)
Biochemistry & Molecular Biology
(27)
Uric Acid - Metabolism
(26)
Physiology
(25)
Biological And Medical Sciences
(21)
Proteins
(21)
Rats, Wistar
(21)
Amino Acids
(20)
Cells, Cultured
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy

Uric Acid Elevation by Favipiravir, an Antiviral Drug

Mechanisms underlying sensitization of P2X7 receptors in astrocytes for induction of ischemic tolerance

l‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth

Functional Expression of Organic Ion Transporters in Astrocytes and Their Potential as a Drug Target in the Treatment of Central Nervous System Diseases

P2X7 Receptors in Astrocytes: A Switch for Ischemic Tolerance

L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism

Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment

Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma

Organic Anion Transporter Family: Current Knowledge

Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective

JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function

Contribution of Rare Variants of the SLC22A12 Gene to the Missing Heritability of Serum Urate Levels

Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways

LAT1-specific inhibitor ameliorates severe autoimmune arthritis in SKG mouse

The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2

Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans

Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma

Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203

c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells

Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer

Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies

Cystine-dependent antiporters buffer against excess intracellular reactive sulfur species-induced stress

Effects of a novel hepatitis B anti-viral drug E-CFCP in renal organic acid transporters

Fluvastatin is effective against thymic carcinoma

Suchergebnisse filtern